Ventricular Assist Devices Market Research Report - Forecast till 2027

Ventricular Assist Devices Market Research Report: By Product Type (Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device), By Type of Flow (Continuous Flow, Pulsatile Flow), By Design (Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device) and By Application (Destination Therapy, Bridging Therapy) – Forecast to 2027

ID: MRFR/HC/8299-HCR | August 2022 | Region: Global | 120 Pages         

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Ventricular Assist Devices Market, by Product Type

1.1.2. Global Ventricular Assist Devices Market, by Type of Flow

1.1.3. Global Ventricular Assist Devices Market, by Design

1.1.4. Global Ventricular Assist Devices Market, by Application

1.1.5. Global Ventricular Assist Devices Market, by Region

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.2.1. Increasing prevalence of cardiovascular disorders

4.2.2. Rising cases of patients with heart failure and shortage of heart donors

4.2.3. Development of technologically advanced products

4.2.4. Increasing number of government initiatives to support medical device manufacturers

4.2.5. Large number of clinical trials in VAD development

4.3. Restraints

4.3.1. Risks associated with a VAD implantation procedure

4.3.2. Unfavorable reimbursement framework

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

5.3. Impact of Covid-19 on Ventricular Assist Devices Market

5.3.1. Impact on Supply Chain

5.3.2. Impact on Production

5.3.3. Impact on Pricing and revenues

5.3.4. Impact on surgical procedures

6. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Left Ventricular Assist Device

6.3. Right Ventricular Assist Device

6.4. Biventricular Assist Device

7. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW

7.1. Overview

7.2. Continuous Flow

7.3. Pulsatile Flow

8. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN

8.1. Overview

8.2. Implantable Ventricular Assist Device

8.3. Transcutaneous Ventricular Assist Device

9. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION

9.1. Overview

9.2. Destination Therapy

9.3. Bridging Therapy

10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitor Dashboard

11.3. Major Growth Strategy in the Global Ventricular Assist Devices Market

11.4. Competitive Benchmarking

11.4.1. The Leading Player in terms of Number of Developments in the Global Ventricular Assist Devices Market

11.5. Key Developments & Growth Strategies

11.6. Major Players Financial Matrix & Market Ratio

12. COMPANY PROFILES

12.1. Medtronic

12.1.1. Company Overview

12.1.2. Products/Services Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Abbott

12.3. Berlin Heart GmbH

12.4. ReliantHeart Inc.

12.5. Abiomed Inc.

12.6. Cardiac Assist Inc.

12.7. Cirtec

12.8. CorWave SA

12.9. Fineheart

12.10. Others

13. APPENDIX

13.1. References

13.2. Related Reports

 

LIST OF TABLES

TABLE 1 GLOBAL VENTRICULAR ASSIST DEVICES MARKET SYNOPSIS, 2017–2027

TABLE 2 GLOBAL VENTRICULAR ASSIST DEVICES MARKET ESTIMATES & FORECAST, 2017–2027 (USD MILLION)

TABLE 3 GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 4 GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 5 GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 6 GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 7 GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2017–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 10 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 11 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 12 US: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 13 US: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 14 US: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 15 US: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 16 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 17 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 18 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 19 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 20 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 21 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 22 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 23 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 24 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 25 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 26 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 27 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT TYPE, 2017–2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE OF FLOW, 2017–2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2017–2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VENTRICULAR ASSIST DEVICES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VENTRICULAR ASSIST DEVICES MARKET

FIGURE 4 GLOBAL VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCT TYPE, 2019 (%)

FIGURE 5 GLOBAL VENTRICULAR ASSIST DEVICES MARKET SHARE, BY TYPE OF FLOW, 2019 (%)

FIGURE 6 GLOBAL VENTRICULAR ASSIST DEVICES MARKET SHARE, BY DESIGN, 2019 (%)

FIGURE 7 GLOBAL VENTRICULAR ASSIST DEVICES MARKET SHARE, BY APPLICATION, 2019 (%)

FIGURE 8 GLOBAL VENTRICULAR ASSIST DEVICES MARKET SHARE, BY REGION, 2019 (%)

FIGURE 9 AMERICAS: VENTRICULAR ASSIST DEVICES MARKET SHARE BY REGION, 2019 (%)

FIGURE 10 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 11 EUROPE: VENTRICULAR ASSIST DEVICES MARKET SHARE, BY REGION, 2019 (%)

FIGURE 12 WESTERN EUROPE: VENTRICULAR ASSIST DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 ASIA-PACIFIC: VENTRICULAR ASSIST DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 14 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 16 MEDTRONIC: KEY FINANCIALS

FIGURE 17 MEDTRONIC: SEGMENTAL REVENUE

FIGURE 18 MEDTRONIC: REGIONAL REVENUE

FIGURE 19 ABBOTT: KEY FINANCIALS

FIGURE 20 ABBOTT: SEGMENTAL REVENUE

FIGURE 21 ABBOTT: REGIONAL REVENUE

FIGURE 22 BERLIN HEART GMBH: KEY FINANCIALS

FIGURE 23 BERLIN HEART GMBH: SEGMENTAL REVENUE

FIGURE 24 BERLIN HEART GMBH: REGIONAL REVENUE

FIGURE 25 ABIOMED INC.: KEY FINANCIALS

FIGURE 26 ABIOMED INC.: SEGMENTAL REVENUE

FIGURE 27 ABIOMED INC.: REGIONAL REVENUE

Ventricular Assist Devices Market

Ventricular Assist Devices Market is projected to be worth USD 1,726 million at CAGR of 11.2 % during the forecast period.

Segmentation

By Product Type Left Ventricular Assist Device Right Ventricular Assist Device Biventricular Assist Device
By Type of Flow Continuous Flow Pulsatile Flow
By Design Implantable Ventricular Assist Device Transcutaneous Ventricular Assist Device
By Application Destination Therapy Bridging Therapy

Key Players

  • Medtronic plc (Ireland)
  • Abbott (US)
  • Berlin Heart GmbH (Germany)
  • ReliantHeart Inc. (US)
  • Abiomed Inc. (US)
  • Cardiac Assist Inc. (US)
  • Cirtec (US)
  • CorWave SA (France)
  • and Fineheart (France) among others.

Drivers

  • Increasing prevalence of cardiovascular disorders- Cardiovascular diseases are the number one cause of deaths globally
  • Increasing number of government initiatives to support medical device manufacturers
Speak to Analyst Request a Free Sample

Ventricular Assist Devices Market Overview


Ventricular Assist Devices Market accounted for USD 1,726 Million in 2019 and it is expected to grow at a CAGR of 11.2% from 2020 to 2027.


A ventricular assist device (VAD) is a miniaturized mechanical pump that is used to support heart function and maintain blood flow to vital organs in patients with weakened hearts. A ventricular assist device can be used if one or both the heart's ventricles don't function properly. Ventricular assist devices play an important role in managing patients with cardiac strokes and heart failures owing to the dearth of heart donors. Thus, there has been a huge demand for VAD and the market will witness an exponential growth during the forecast years.


Furthermore, the current outbreak of COVID-19 along with an increasing number of manufacturers in various regions is driving the ventricular assist devices market for ventricular assist devices.


Market Influencer


Increasing demand for VADs owing to a shortage of heart donors drives the global ventricular assist devices market.


Market Drivers



  • Increasing prevalence of cardiovascular disorders- Cardiovascular diseases are the number one cause of deaths globally. According to the 2019 report of WHO, nearly 17.9 million people died due to cardiovascular diseases in 2018 which is about 31% of the total deaths. The increasing prevalence of these diseases is likely to create demand for VADs and push the ventricular assist devices market growth from 2020 to 2027.



  • High burden of CVD on the healthcare system- 2019 CDC report states that CVD burden on the US health care system is nearly USD 214 billion each year



  • Shortage of heart donors resulting in increased demand for VADs



  • Development of technologically advanced products



  • Increasing number of government initiatives to support medical device manufacturers



  • A large number of clinical trials in VAD development. More than 200 clinical studies are being carried out across the globe as of June 2020. These clinical trials are being conducted by various companies, research organizations, and universities. Some of the major companies involved in these studies are Abbott, Medtronic, and Berlin Heart GmbH among others.


Market Restraints



  • Risks associated with a VAD implantation procedure

  • Unfavorable reimbursement framework


Segmentation


By Product Type



  • Left Ventricular Assist Device (LVAD): This segment accounted for the largest market share in the global ventricular assist devices market. A LVAD is a pump that is used for patients who have reached end-stage heart failure. LVAD is surgically implanted and helps the left ventricle pump blood to the rest of the body. This segment is the major revenue contributing factor in this market as the number of LVAD implantations heart failure patients is quite high as compared to RVAD. As a result, a number of companies have developed advanced products to improve treatment outcomes. For instance, Abbott has successfully implanted its HeartMate II LVAD in more than 26,600 patients till now.



  • Right Ventricular Assist Device (RVAD): Right ventricular assist device supports the left ventricle of the heart and helps in pumping the blood into the pulmonary artery and to the lungs.



  • Biventricular Assist Device: This technically is not a separate type of ventricular assist devices. However, when both the ventricles of a patient fail to function, both LVAD and RVAD are implanted into the patient at the same time which is called BIVAD.


By Type of Flow



  • Continuous Flow: Continuous flow left ventricular assist devices (CFVAD) are currently the most widely used type of VAD. CFVADs offer advantages of smaller size, increased reliability & durability, and subsequent improvements in survival. It accounts for the largest market share and is also the fastest-growing segment in the global ventricular assist devices market. Medtronic’s HeartWare is an example of a continuous flow of VAD.



  • Pulsatile Flow: Pulsatile flow VADs use positive displacement pumps which mimics the natural pulsing action of the heart. They are relatively noisier, require regular maintenance and early replacement due to the continuous rotation of moving parts. Pulsatile flow VADs are less preferred compared to continuous flow, thus they are expected to exhibit a moderate ventricular assist devices market growth during the forecast period.


By Design



  • Implantable Ventricular Assist Device: This segment captured the largest market share in 2019. An implantable VAD has a design wherein its pump is implanted inside the body, and its power source is located outside the body. A cable connects the pump to the power source through a small hole in the abdomen. Implantable VADs are used when a patient is waiting for a heart transplant or as a long-term solution if a patient is not eligible for transplant procedure due to other medical complications.



  • Transcutaneous Ventricular Assist Device: A transcutaneous VAD has design wherein both its pump and power source are located outside of the body. Tubes connect the pump to the heart through small holes in the abdomen. Transcutaneous VAD is generally used for short-term support during or after surgery.


By Application



  • Destination Therapy: It is an end-stage therapy where the VADs are implanted in severe heart failure patients, and in the patients, who are not eligible for the transplantation. The VADs remain in the patient’s body for the rest of their lifespan. With the increasing dearth of heart honors and heart failure patients, this is the segment contributes to the largest share in the global ventricular assist devices market.



  • Bridging Therapy: Bridging therapy is growing at a significant rate. There are three subsets to this therapy. Bridge to transplantation; where the VADs are implanted until the patient is ready for the transplant procedure. Bridge to recovery; where the VADs are implanted post the transplantation which supports the patient’s heart while it recovers and starts normal functioning. Bridge to candidacy; where VADs are implanted in the patients who are sick till they come to a state of being eligible for transplantation procedure.


By Region



  • Americas: The Americas dominated the ventricular assist devices market in 2019 owing to the high number of patients suffering from cardiovascular diseases and less availability of heart donors. According to the CDC report published in 2017, nearly 6.5 million people have heart failure in the US each year. American Heart Association states that the number of people diagnosed with heart failure is increasing and projected to rise by 46% by 2030.



  • Europe: Europe is projected to show exponential growth in the ventricular assist devices market. The high prevalence of the cardiovascular disease is the major factor pushing the growth of the ventricular assist devices market in the region. 2017 report of European Heart Network states that each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Besides, in Europe, there are companies like the Berlin Heart which are involved in the development of new products and providing treatment options for different age groups. For instance, in February 2020, Berlin Heart GmbH Company’s EXCOR Active has received CE marking and is now supporting pediatric heart patients in Germany.



  • Asia-Pacific: the Asia Pacific is anticipated to witness significant growth rate over the forecast period owing due to increasing chronic cardiovascular diseases, rising healthcare expenditure, and a rise in the number of collaborations & strategic agreements among major market players. Moreover, increasing medical tourism for cardiac surgeries in countries like India, Malaysia, and Singapore among others is one major factor pushing the growth of the market in this region. Also, government initiatives such as “Make in India” are encouraging the local players to enter into the manufacturing of medical devices and boost the ventricular assist devices market growth.



  • Middle East & Africa: The increasing rate of cardiovascular diseases in one of the major factors in VAD market growth in the region. The number of people dying from CVD is quite high in the Middle East. According to the report published by the Institute of Health Metrics and Evaluation in 2018, nearly 36% of deaths in UAE are caused by cardiovascular diseases. Moreover, the developing healthcare infrastructure and growing innovative product options for the aging population with heart conditions are also boosting the ventricular assist devices market growth in this region.


Key Players



  • Medtronic plc

  • Abbott

  • Berlin Heart GmbH

  • ReliantHeart Inc.

  • Abiomed Inc.

  • Cardiac Assist Inc.

  • Cirtec

  • CorWave SA

  • Fineheart



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2019: USD 1,726 Million
  • 2027: Significant Value
  •   CAGR   11.2% (2020-2027)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product Type, Type of Flow, Design and Application
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Medtronic plc (Ireland), Abbott (US), Berlin Heart GmbH (Germany), ReliantHeart Inc. (US), Abiomed Inc. (US), Cardiac Assist Inc. (US), Cirtec (US), CorWave SA (France), and Fineheart (France) among others.
      Key Market Opportunities   Increasing Demand for VADs owing to a shortage of heart donors drives the Global Ventricular Assist Devices Market.
      Key Market Drivers

  • Increasing prevalence of cardiovascular disorders- Cardiovascular diseases are the number one cause of deaths globally.
  • High burden of CVD on the healthcare system- 2019 CDC report states that CVD burden on the US health care system is nearly USD 214 billion each year.
  • Increasing number of government initiatives to support medical device manufacturers.


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    A ventricular assist device (VAD) is a miniaturized mechanical pump that is used to support heart function and maintain blood flow to vital organs in patients with weakened hearts. A ventricular assist device can be used if one or both the heart's ventricles don't function properly.

    Ventricular Assist Devices Market is expected to record a substantial market valuation past the recorded 2019 value of USD 1.7 billion.

    Ventricular Assist Devices Market is projected to register a moderate 11.2% CAGR in the forecast period.

    The LVAD segment is expected to observe substantial demand over the review period.

    The destination therapy segment is slated to expand as the fastest-growing segment.

    A few emminent market players operating in the global ventricular assist devices market are Medtronic plc, abbott, cirtec, among others.